|

Study of the No-touch Saphenous Vein Graft

RECRUITINGN/ASponsored by Meshalkin Research Institute of Pathology of Circulation
Actively Recruiting
PhaseN/A
SponsorMeshalkin Research Institute of Pathology of Circulation
Started2022-12-22
Est. completion2025-04-01
Eligibility
Age25 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05757947

Summary

Authors hypothesize that "no-touch" saphenous vein as I graft is superior over conventional "no-touch" saphenous vein as free graft in the incidence of graft patency.

Eligibility

Age: 25 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with coronary artery disease requiring three-vessel myocardial revascularization
* Patient consent to the study

Exclusion Criteria:

* The diameter of the target arteries for conduits of the internal mammary arteries is less than 1 mm
* Hemodynamically significant atherosclerosis of the subclavian arteries in the first segment
* Stenosis of the right coronary artery less than 90%
* Concomitant pathology requiring additional simultaneous surgical correction
* Lack of IMA
* COPD with FEV1 \<60%
* BMI \>35
* Prior heart surgery
* Oncological diseases with a life expectancy of less than 5 years
* ACS
* CKD stage 4 and higher
* The diameter of the SVG is less than 2 mm or its varicose expansion is more than 6 mm
* CLTI IIb and more
* Atherosclerosis of the brachiocephalic artery more than 50%

Conditions6

Cardiac IschemiaCoronary Artery DiseaseCoronary Artery StenosisGraft FailureHeart DiseaseSurgery

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.